Matthew Price, community development manager at Brain Tumour Research said: ‘We’re really grateful to Weronika for taking part in the 100 Squats or Star Jumps a Day in November Challenge, as it’s only with the support of people like her that we’re able to progress our research into brain tumours and improve the outcome for […]
Although the company will continue to pursue « higher-risk, high reward » drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky. Flair also analysed dozens of open letters published by alumnae of private schools who complained last year about racist abuse they had […]
Matthew Price, community development manager at Brain Tumour Research said: ‘We’re really grateful to Weronika for taking part in the 100 Squats or Star Jumps a Day in November Challenge, as it’s only with the support of people like her that we’re able to progress our research into brain tumours and improve the outcome for […]
